Latest AI and machine learning research in allergy & immunology for healthcare professionals.
Hyperuricemia is a well-established direct trigger of gouty arthritis. Xanthine oxidase (XO), the ra...
BACKGROUND: The Dutch flagship project Next Generation ImmunoDermatology (NGID) aims to profile five...
PURPOSE: Programmed cell death ligand-1 (PD-L1) is a key prognostic and predictive biomarker for imm...
Cancer immunotherapies trigger highly variable responses in patients and in genetically identical mo...
T cells are central to the adaptive immune response, capable of detecting pathogenic antigens while ...
INTRODUCTION: Preschool wheeze and asthma are associated with substantial morbidity and impaired fut...
Esophageal squamous cell carcinoma (ESCC) remains a major health burden, particularly in Asia, with ...
Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, ranks as the fourth le...
Tumor Mutational Burden (TMB) is a widely used biomarker for selecting cancer patients for immune ch...
Immune checkpoint inhibitors (ICI) have improved clinical outcomes for some patients with advanced N...
This study systematically predicts prognosis and key gene targets for immunotherapy in hepatocellula...
BACKGROUND AND OBJECTIVES: The development of viral resistance can significantly reduce the effectiv...
BACKGROUND: Transgender women (TGW) and men who have sex with men (MSM) are disproportionately affec...
The epidermal growth factor receptor (EGFR) is a key target in cancer therapy, mainly in non-small c...
PURPOSE: Endoscopically identifying eosinophilic esophagitis (EoE) is difficult due to its rare inci...
The discovery of natural killer (NK) cells stands among the fundamental milestones in modern immunol...
Purpose To evaluate the predictive value of myosteatosis as an opportunistic finding in coronary art...
PURPOSE: Missing information is common in real-world claims data, particularly on behavioral confoun...
OBJECTIVES: Detection of antinuclear antibody (ANA) via indirect immunofluorescence (IIF) on HEp-2 c...
Recent advancements in cancer immunotherapy have transformed clinical oncology, with monoclonal anti...
INTRODUCTION: Proton pump inhibitors (PPIs) are widely used to treat acid-related disorders; however...